Financial Summary -
Angelini Pharmaceuticals Romania Srl
Unique identification code:27723506
Registration number:J2010011231409
Nace:4646
Sales - Ron
45.426.000
Net Profit - Ron
3.064.347
Employees
Open Account
Company Angelini Pharmaceuticals Romania Srl with Fiscal Code 27723506
recorded a turnover of 2024 of
45.426.000,
with a net profit of
3.064.347
and having an average number of employees of
- .
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Angelini Pharmaceuticals Romania Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
34.677.680
27.865.372
26.653.390
28.055.857
29.011.335
32.591.964
27.029.521
35.383.283
39.036.901
45.426.000
Total Income - EUR
35.464.565
26.673.013
26.663.320
28.214.970
29.200.925
32.851.159
27.218.250
35.871.591
39.649.769
46.179.666
Total Expenses - EUR
33.124.300
29.567.401
25.894.705
28.832.310
28.518.340
30.970.520
25.446.785
33.284.877
36.397.143
42.622.039
Gross Profit/Loss - EUR
2.340.265
-2.894.388
768.615
-617.340
682.584
1.880.639
1.771.465
2.586.714
3.252.626
3.557.627
Net Profit/Loss - EUR
1.993.180
-3.143.489
621.113
-814.835
429.740
1.530.082
1.529.930
2.078.247
2.653.379
3.064.347
Employees
94
90
102
97
0
88
77
77
10
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 17.0%, from 39.036.901 euro in the year 2023, to 45.426.000 euro in 2024.
The Net Profit increased by 425.797 euro, from 2.653.379 euro in 2023, to 3.064.347 in the last year.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Angelini Pharmaceuticals Romania Srl - CUI 27723506
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
188.618
235.326
211.777
148.655
165.719
135.951
92.914
67.102
58.370
54.756
Current Assets
33.722.036
24.024.937
21.072.779
24.430.616
27.497.876
27.834.627
29.309.012
30.263.175
30.481.929
34.153.164
Inventories
2.201.154
1.914.116
1.052.238
979.524
813.775
844.004
1.301.939
2.116.717
3.660.287
4.714.973
Receivables
18.486.557
20.369.305
19.563.610
21.266.708
21.635.472
18.020.642
18.996.659
20.792.821
21.124.411
20.124.405
Cash
13.034.324
1.741.516
456.932
2.184.383
5.048.629
8.969.981
9.010.414
7.353.636
5.697.232
9.313.786
Shareholders Funds
16.839.351
13.503.116
12.270.854
11.230.826
11.443.069
12.756.218
14.003.267
11.031.394
10.266.875
10.797.016
Social Capital
14.375.748
14.229.135
13.988.354
13.731.643
13.465.714
13.210.436
12.917.482
6.995.843
6.974.629
6.935.649
Debts
16.906.992
6.512.404
8.853.748
11.734.482
14.388.215
13.064.244
13.611.305
17.354.877
18.260.680
22.712.806
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
34.153.164 euro in 2024 which includes Inventories of
4.714.973 euro, Receivables of
20.124.405 euro and cash availability of
9.313.786 euro.
The company's Equity was valued at
10.797.016 euro, while total Liabilities amounted to
22.712.806 euro.
Equity increased by 587.520 euro, from 10.266.875 euro in 2023, to 10.797.016 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Angelini Pharmaceuticals Romania Srl